Completed Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth NCT00685503 Conditions Metaplasia, Neovascularization, Neovascularization, Pathologic, +2 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
Completed Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization NCT00645697 Conditions Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +13 more Locations American University of Beirut — Beirut, Lebanon View Trial Details
Active, Not Recruiting Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever NCT05152524 Conditions Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +10 more Locations Lakewood Regional Medical Center — Los Angeles, California, United States Los Robles — Thousand Oaks, California, United States WellStar Research Institute — Marietta, Georgia, United States Advocate Aurora Research Institute, — Chicago, Illinois, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial NCT04844619 Conditions Eye Diseases, Glaucoma, Glaucoma, Neovascular, +7 more Locations Zhongshan Ophthalmic Center — Guangzhou, Guangdong, China View Trial Details
